+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Venlafaxine"

Bipolar Disorder Therapeutics Market by Therapeutics, Mechanism Of Action, Drug Administration Route, Patient Age Group, End User, Treatment Duration - Global Forecast 2025-2030 - Product Thumbnail Image

Bipolar Disorder Therapeutics Market by Therapeutics, Mechanism Of Action, Drug Administration Route, Patient Age Group, End User, Treatment Duration - Global Forecast 2025-2030

  • Report
  • October 2024
  • 192 Pages
  • Global
From
Episodic Ataxia Treatment Market Report 2024 - Product Thumbnail Image

Episodic Ataxia Treatment Market Report 2024

  • Report
  • October 2024
  • 175 Pages
  • Global
From
CNS Therapeutics - Global Strategic Business Report - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

  • Report
  • March 2025
  • 898 Pages
  • Global
From
Antidepressants - Global Strategic Business Report - Product Thumbnail Image

Antidepressants - Global Strategic Business Report

  • Report
  • March 2025
  • 174 Pages
  • Global
From
Antidepressants Market Report 2025 - Product Thumbnail Image

Antidepressants Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Anxiety Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Anxiety Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 129 Pages
  • Global
From
Panic Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Panic Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 139 Pages
  • Global
From
Generalized Anxiety Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Generalized Anxiety Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 138 Pages
  • Global
From
Peripheral Neuropathic Pain - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Peripheral Neuropathic Pain - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 260 Pages
  • Global
From
Treatment Resistant Depression - Pipeline Insight, 2024 - Product Thumbnail Image

Treatment Resistant Depression - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Cataplexy - Pipeline Insight, 2024 - Product Thumbnail Image

Cataplexy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026 - Product Thumbnail Image

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026

  • Report
  • February 2021
  • 420 Pages
  • United States
From
Research Report on China's Venlafaxine Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Venlafaxine Market, 2021-2025

  • Report
  • September 2021
  • 40 Pages
  • China
From
Peripheral Neuropathy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030 - Product Thumbnail Image

Peripheral Neuropathy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030

  • Report
  • August 2022
  • 117 Pages
  • Global
From
Postpartum Depression - Market Insights, Epidemiology, and Market Forecast - 2032 - Product Thumbnail Image

Postpartum Depression - Market Insights, Epidemiology, and Market Forecast - 2032

  • Report
  • August 2023
  • 133 Pages
  • Global
From
Treatment- Resistant Depression Market- Growth, Trends, Covid-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Treatment- Resistant Depression Market- Growth, Trends, Covid-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • August 2022
  • 120 Pages
  • Global
From
Anxiety Disorders and Depression Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Anxiety Disorders and Depression Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 120 Pages
  • Global
From
Anxiety Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Thumbnail Image

Anxiety Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • November 2023
  • 190 Pages
  • Global
From
Fragile X Syndrome Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021 - 2030 - Product Thumbnail Image

Fragile X Syndrome Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021 - 2030

  • Drug Pipelines
  • February 2022
  • 60 Pages
  • Global
From
Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Product (Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Central Nervous System Stimulants, Tricyclic Antidepressants), By Regional Outlook and Forecast, 2022 - 2028 - Product Thumbnail Image

Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Product (Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Central Nervous System Stimulants, Tricyclic Antidepressants), By Regional Outlook and Forecast, 2022 - 2028

  • Report
  • August 2022
  • 170 Pages
  • Global
From
Loading Indicator

Venlafaxine is a medication used to treat depression, anxiety, and panic disorder. It is a serotonin-norepinephrine reuptake inhibitor (SNRI) and is classified as a Central Nervous System (CNS) drug. Venlafaxine works by increasing the levels of serotonin and norepinephrine in the brain, which helps to improve mood and reduce anxiety. It is available in both immediate-release and extended-release formulations. Common side effects include nausea, headache, insomnia, and dry mouth. Venlafaxine is a widely prescribed medication and is available in generic form. It is marketed by several pharmaceutical companies, including Pfizer, GlaxoSmithKline, and Mylan. It is also available in combination with other medications, such as bupropion and olanzapine. Venlafaxine is available in both brand-name and generic forms, and is available in a variety of dosage forms, including tablets, capsules, and oral solutions. Show Less Read more